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Impact of a Multidisciplinary Heart Failure Management
Programme on Clinical Outcomes and Hospital Admissions
TAT-CHI LEUNG,1 CHUNG-TAI SY,1 MAY SHUK-MAI LAM,1 KAM-WAH WONG,2 SAI-HO DAI,3 PUI-YEE
LAW,4 SHU-KIN LI1
From 1Department of Medicine, 2Department of Physiotherapy, 3Department of Occupational Therapy, 4Department
of Dietetic, Pamela Youde Nethersole Eastern Hospital, Hong Kong
LEUNG ET AL.: Impact of a Multidisciplinary Heart Failure Management Programme on Clinical Outcomes
and Hospital Admissions. Objectives: Heart failure is associated with significant morbidity and high admission
rate. We evaluated the impact of a multidisciplinary heart failure management programme in a regional hospital.
Methods: From March 2001 to January 2003, fourteen patients with heart failure and history of ≥1 hospitalization
for heart failure in the previous 6 months were recruited. Patients attended the programme twice per week for
3 months. Patients were cared by a multidisciplinary team including cardiologist, geriatrician, registered nurse,
physiotherapist, occupational therapist and dietitian. All patients were counseled on different aspects about heart
failure and received exercise training. Medications for heart failure were optimized. Knowledge of the disease, drug
compliance, functional class, exercise capacity and quality of life were assessed before and after the programme.
Number of heart failure hospitalization and the cost of care within the 6 months before enrolment were compared to
that within the 6 months after enrolment. Results: The number of hospitalization for heart failure was reduced
significantly from 28 to 6 (a reduction of 78.6%, p<0.001). Knowledge score, drug compliance score, New York
Heart Association (NYHA) class, 6-minute walk and quality of life scores all improved significantly. An estimated
cost saving of HK$11,340 per patient was achieved over a 6-month time frame (reduction of in-patient costs by
HK$35,880 per patient and an increase in outpatient costs by HK$24,540 per patient). Conclusions: Multidisciplinary
heart failure management programme is feasible in our locality. It can improve clinical outcomes; reduce heart
failure hospitalizations and the high cost burden of this condition. (J HK Coll Cardiol 2004;12:16-22)
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Background
Heart failure is a growing public health problem
in Hong Kong and in many other countries. Both the
incidence and the prevalence of chronic heart failure
are increasing. Heart failure is associated with poor
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prognosis, reduced quality of life and is one the most
significant causes of hospital admissions. In the United
States, the incidence of heart failure approaches 10%
per 1,000 population after age 65.1 Heart failure accounts
for 5 to 10% of all hospitalizations in the United States
annually, and is the leading cause of hospitalization in
individuals older than 65 years of age. Hospital
discharges for heart failure increased for more than three
times from 1979 to 1997. Readmission rate for
congestive heart failure is very high, with half of the
patients readmitted within 6 months.2,3 In Hong Kong,
heart failure is also an important cause of hospital
admissions.4 The overall incidence was 0.7 per 1,000
population, whereas in the older than 85-year age group,
the incidence was 20 per 1000 women and 14 per 1,000
men.5 Cost of care for heart failure is very substantial
because of the high hospitalization and rehospitalization
rate. In the United States, heart failure costs about
US$38 billion annually, of which approximately twothirds of this amount are spent on hospitalizations.6,7
Non-compliance to optimal pharmacological,
dietary or physical activity regimens is a major cause
for heart failure decompensation.8 It has been shown
that early re-hospitalization in patients with heart failure
may be preventable in up to 50% of cases.2,9,10 These
preventable negative factors include noncompliance
with medications or diet, inadequate discharge planning
or follow-up, and failure to seek medical attention
promptly when symptoms recur. Recent studies have
shown that multidisciplinary heart failure disease
management programme can improve the clinical
outcomes and quality of life of patients with heart
failure, and reduce hospital admissions and resources
utilization.11-18
We designed and implemented a multidisciplinary management programme for heart failure
patients in our hospital to determine whether this kind
of programme is feasible and beneficial in our locality.
The objectives of the programme were to optimize the
medications; to improve the quality of life, compliance,
symptoms, and functional status of patients with heart
failure; to decrease the hospital admissions and cost
of care for heart failure through multidisciplinary
management approach.
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Methods
Patient Selection
From March 2001 to January 2003, patients
admitted to Pamela Youde Nethersole Eastern Hospital
with a primary diagnosis of congestive heart failure were
screened for enrolment. The inclusion criteria were: age
>18; moderate to severe symptomatic heart failure
(NYHA Class II to IV); history of 1 or more than
1 hospitalization for heart failure in the previous
6 months.
The criteria for exclusion from the study
included: acute myocardial infarction within 4 weeks
of entry; unstable coronary artery disease, acute
myocarditis, constrictive pericarditis and other
significant co-morbid conditions such as dementia
or malignancy that likely to limit compliance or
survival.

Baseline Evaluation and Outcome Measurement
Baseline evaluation included a history and
physical examination performed by a cardiologist.
Echocardiography was performed to assess the left
ventricular function if it had not been performed in the
previous six months.
Each patient was his/her own control and a
comparison was made before and after the intervention.
Data were obtained at entry to the study and at the end
of the programme. Assessments included knowledge
of the disease; drug compliance; sodium intake; New
York Heart Association Class; exercise capacity
measured by 6-minute walk test; quality of life using
the Minnesota Living with Heart Failure Questionnaire.19
Sodium intake was assessed using a food frequency
questionnaire. Each participant was interviewed by a
dietitian with respect to food portion size, intake of food
containing sodium, frequency of intake per week and
month. Hospital diet was used as a reference to sodium
level of seasoning. Average daily sodium intake was
calculated based on the nutrient database of Nutritional
Five (First DataBank Inc., 1998) and commercial food
labeling. Knowledge of the disease was assessed by a
set of 21 questions designed by our team, regarding the
symptoms and worsening symptoms of heart failure;
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the proper diet and physical activities. Drug compliance
was assessed by asking the patients 6 questions
regarding the name, dosage, frequency, route of
administration and side effects of the medications for
heart failure.
Number of heart failure hospitalization within the
6 months before enrolment was compared to that within
the 6 months after enrolment. Death and other
significant morbidity were also recorded.
Medications usage and dose were recorded at
baseline and at end of the programme. Angiotensin
converting enzyme inhibitors (ACE-I) were grouped and
ranked according to dose: 'low dose' ≤10 mg/day of
lisinopril or equivalent, 'medium dose' 10 to <20 mg/
day lisinopril or equivalent; and 'high dose' ≥20 mg/
day lisinopril or equivalent. Similarly, beta-blockers
were also ranked according to dose: 'low dose' ≤12.5
mg/day carvedilol or equivalent; 'medium dose' 12.5 to
<50 mg/day carvedilol or equivalent; 'high dose' ≥50
mg/day carvedilol or equivalent.

nurse on different aspects of heart failure with emphasis
on warning symptoms and signs of deterioration; and
the importance of daily weighing. Each patient also
received an educational booklet on heart failure. Patients
and their caretaker received advice from the dietitian
regarding diet, fluid and sodium management. Energy
conservation technique, work simplification advice and
relaxation practice were given by the occupational
therapist.
All patients were assessed individually by the
physiotherapist and received exercise training designed
for heart failure patients. The exercise programme lasted
for 3 months, two times per week. It included a
combined programme of treadmill exercise, static bike
riding and upper limb ergometer training. Patients were
exercised to a heart rate of 50-60% of maximum
predicted for age and a Borg rating of 9-12 for perceived
exertion. Patients were encouraged to maintain a home
programme of daily walking for a total period of
exercise 30-minute per day, 5-7 days per week.

Multidisciplinary Management Programme

Statistical Method

Patients attended the programme twice per week
for about 3 months which took place at the Day Hospital
of the Pamela Youde Nethersole Eastern Hospital.
Patients were cared by a multidisciplinary team. The
team included a cardiologist, a geriatrician, a registered
nurse, a physiotherapist, an occupational therapist and
a dietitian.
Each patient received an initial consultation with
the cardiologist or the geriatrician. This was a
comprehensive assessment of the patient's heart failure
status. A monthly conference was held to discuss the
progress of the patients. Followed-up review by
physician would be arranged if required.
Medications for heart failure, especially
angiotensin converting enzyme inhibitors and betablockers were optimized according to the ACC/AHA
heart failure management guideline.20 The side effect
and the importance of drug treatment were emphasized.
Instructions on the use of a flexible diuretic regimen
and dosage adjustment in response to worsening
symptoms and weight change were given.
All patients were counseled by the registered

The baseline demographic data were expressed
as mean and standard deviation. The changes between
the data obtained before and after the programme were
analyzed using paired t-test. A p-value less than 0.05
was considered to be statistically significant. Analyses
were performed using SPSS (version 10.0).
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Results
Patient Population
From March 2001 to January 2003, fourteen
patients with heart failure and history of ≥1
hospitalization for heart failure in the previous 6 months
were recruited. The mean age was 71.9±5.9 (range 6184). The male to female ratio was 1:1. The mean ejection
fraction was 38.5±15.0%. Most patients were in NYHA
Class III (71.4%), 21.4% of patients in Class II and
7.1% in Class IV. The etiology of heart failure were:
ischemic cardiomyopathy (50%), dilated
cardiomyopathy (14.2%), hypertensive heart disease
(21.4%) and valvular heart disease (14.2%). All
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patients completed the programme. No patient died
during follow-up up to 6 months.

Hospitalizations (Figure 1)
Hospitalizations were significantly reduced. In
the 6 months prior to the start of the programme, the
total number of hospitalizations for heart failure was
28. The mean number of hospitalizations for heart
failure per patient was 2.0. In the 6 months after
enrollment to the programme, the total number of
hospitalizations for heart failure was 6. The mean
number of hospitalizations per patient was 0.43.
Hospitalization for heart failure was reduced by 78.5%
(p<0.001). Bed days were significantly reduced from a
total of 362 days (of which 177 were acute bed days,
185 were convalescent bed days) to 165 days following
the programme (of which 15 were acute bed days and
150 were convalescent bed days) (p<0.001). Outpatient
clinic attendance also reduced from 34 to 24 following
the programme.

Drug Therapies
At baseline, 71.4% of patients were receiving
ACE-I or angiotensin receptor blocker (ARB), 70% or
them were receiving high dose. At the end of the
programme, 78.8% were receiving ACE-I or ARB and

21.4% of patients had a dose increment from their
baseline dose. Regarding beta-blockers, 35.7% of
patients were taking them at baseline: 60% were on low
dose; 40% on medium dose; and none on high dose. At
follow-up, 50% of patients were on beta-blockers of
whom 14.3% were on low dose; 57.1% were on medium
dose and 28.6% were on high dose and 35.7% of study
patients had a dose increment.

Functional Status and Quality of Life (Table 1)
A significant improvement in symptoms and
functional status was found. The NYHA Class improved
from 2.9±0.6 at baseline to 1.7±0.4 at follow-up (p<0.001).
Exercise capacity as measured by 6-min walk test also
improved from a mean of 289.3±67.5 meters to 339.1
±67.8 meters (p=0.005). Quality of life improved
significantly after the programme. The Minnesota
Living with Heart Failure Questionnaires improved
from a score of 39.4±7.6 to 16.4±10.4 following the
programme (p=0.001).

Knowledge, Drug Compliance and Sodium
Intake (Table 1)
Both the knowledge of the disease and drug
compliance improved after the programme. The
knowledge score improved from 19.9±1.5 at baseline

Figure 1. Total number of hospital admissions for heart failure in the 6 months before and
after the programme (reduction of 78.6%, p<0.001).
J HK Coll Cardiol, Vol 12
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to 22.8±1.6 (p<0.001) at follow-up. The drug
compliance score improved from 3.9±0.2 to 5.7±0.5
(p=0.001). The estimated daily sodium intake was 3.4 g
and 3.3 g before and after the programme respectively
(p: n.s.).

Costs (Table 2)
The cost of care for different modalities were
calculated by the finance department of our hospital,
using the specialty costing exercise model and taking
into account of the labour cost of different disciplines,
cost for drugs and equipment. The average cost per bed
day for acute bed was HK$2,662 and for convalescent
bed was HK$2,031. The average cost per out-patient
clinic attendance was HK$1,024 and per visit to the
programme (Day Hospital visit) was HK$1,404.
Comparing the cost of care in the 6 months prior the
programme with that spent in the 6 months following
enrolment, there was a reduction of inpatient costs by
HK$35,880 per patient and an increase in outpatient
costs by HK$24,540 per patient. An estimated cost
saving of HK$11,340 per patient over a 6-month time
frame was achieved.

Discussion
There is growing evidence in supporting a multidisciplinary management approach to patients with
chronic heart failure.11-18 Increasing input into outpatient
care can reduce expensive hospital readmissions. Based
on available evidence, it is appropriate to recommend
widespread development and application of
multidisciplinary heart failure disease management. Our
study, although involved only a small number of
patients, demonstrated that multidisciplinary heart
failure disease program is effective in reducing hospital
admissions, hospital days and cost of care; enhancing
patient knowledge and compliance with medications;
improving functional capacity and quality of life. The
only non-significant finding in our study was the
estimated daily salt intake before and after the
intervention.
Drug therapies, especially ACE-I and betablockers, have been shown to improve survival and
reduce hospitalizations in patients with heart failure.
Optimization of drug therapies was one of the objectives
of our programme. We observed that by the end of the

Table 1. Summary of the effects of the multidisciplinary heart failure programme
Pre-programme
2.9±0.6
289.3±67.5
39.4±17.6
19.9±1.5
3.9±0.2
3.4

NYHA Class
6-minute walk (meters)
Quality of life (Minnesota HF questionnaire 0-105)
Knowledge score (0-21)
Drug compliance score (0-6)
Estimated daily sodium intake (gram)

Post-programme
1.7±0.4
339.1±67.8
16.4±10.4
22.8±1.6
5.7±0.5
3.3

p-value
<0.001
0.005
0.001
<0.001
0.001
n.s.

Table 2. Comparison of resource utilizations and cost of care per patient in the 6 months before and after the
programme

Acute bed days
Convalescent bed days
Outpatient clinic visit
Day hospital visit
Cost savings (Total)

20

Pre-programme number /
Cost (HK$)
177 / 33,655
185 / 26,838
34 / 2,487
2 / 201
-----

Post programme number /
Cost (HK$)
15 / 2,852
150 / 21,761
24 / 1,755
254 / 25,473
-----

January/April 2004

Cost savings
(HK$)
30,803
5,077
732
-25,272
11,340
(p<0.001)
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study, the usage of ACE-I and beta-blockers were
improved. We believed that the improvement in various
parameters after intervention in our study could be partly
contributed by a better medical regimen. However, the
improvement was unlikely to be related entirely to the
introduction and up-titration of medical treatment,
because patients who could not tolerate beta-blocker
still demonstrated no hospitalizations in the follow-up
period.
Most published trials were done at academic
centre in other countries while non-academic centres
may lack the necessary facilities and personnel to
assemble an effective heart failure management team.
Our study demonstrated that this kind of multidisciplinary programme is feasible in our locality and
could be implemented in a regional hospital. It is
necessary, before implementing the programme, to
consider a variety of disease management models, to
select and modify the model most suited to a given
practice environment because a single, unified approach
is unlikely to be applicable to different practice settings.

Lastly, the programme was multidisciplinary and
the relative contributions of its various components
could not be assessed. Future studies are needed to
determine the relative merits of each component of the
programme.

Conclusions
This is one of the first studies to assess a
comprehensive multidisciplinary management
programme specific to heart failure in our locality. Our
study showed that a multidisciplinary approach with
intensive outpatient care improves patient outcomes,
reduces heart failure admissions and the high cost
burden of this disease. Such management could be
implemented in our locality and may become the
standard care for heart failure patients, especially those
with high risk of admission.
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